Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-γ-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatment

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Gut

Topics

Medicine

Immunology

Internal Medicine

Gastroenterology

Psoriasis

Show all topics

DOI

10.1136/gutjnl-2012-302853

Other Formats

PDF